The Centers for Disease Control and Prevention earlier this month said it is taking steps to prepare for the possible spread of H1N1 swine influenza viruses.

The group of viruses, labeled “G4” Eurasian avian-like H1N1 viruses, are believed to be highly adaptable for human infection.

CDC said it is taking a number of actions to monitor and prepare against this emerging public health threat, including:

  • coordinating with public health partners in China, including requesting a virus sample;
  • assessing the risk of the virus causing a pandemic using CDC’s Influenza Risk Assessment Tool;
  • evaluating whether an existing candidate vaccine virus against a closely related flu virus (called “G5”) would protect against this virus;
  • if needed, creating a new candidate vaccine virus specific to G4 viruses; and
  • studying whether existing flu antiviral drugs offer protection against this group of viruses.

Related News Articles

Adam Myers, M.D., population health chief at Cleveland Clinic, talks with Nancy Foster, AHA vice president for quality and patient safety, about preventing flu…
The Food and Drug Administration yesterday released an updated template for developers requesting emergency use authorization for antigen tests for…
To continue amplifying the important message of protecting against both the flu and COVID-19, AHA’s United Against the Flu campaign today released new…
In this AHA podcast, Rita Carreon, deputy vice president for health, UnidosUS, and Elisa Arespacochaga, vice president of the AHA’s Physician Alliance, discuss…
The American Medical Association today released for immediate use Current Procedural Terminology codes for reporting on medical claims two laboratory tests (…
The Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response yesterday awarded to Denver Health and…